Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Added to Liraglutide and Metformin in Type 2 Diabetes
NCT01937598Phase 3Completed
- Start
- Aug 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM). Started Aug 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01937598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937598.